[1]
O. V. Welchinska, “Study of the use possibility of the chemical-biological adduct of the 1,1-bis-[5-bromopyrimidine-2’,4’-diono-1’-il]-2-bromo-2’-chloroethylene and bacterial lectin for the treatment of the Pliss’ lymphosarcoma”, Zaporozhye Medical Journal, vol. 17, no. 2, Apr. 2015.